Guilin Sanjin Pharmaceutical

What Guilin Sanjin Pharmaceutical does

Guilin Sanjin Pharmaceutical Co., Ltd. (桂林三金药业股份有限公司) is a publicly listed Chinese traditional Chinese medicine (TCM) manufacturer, traded on the Shenzhen Stock Exchange under ticker 002275. The company, headquartered in Guilin/Lingui, Guangxi, has been in continuous operation since 1967 and operates with a workforce in the 1,001–5,000 range. Its commercial portfolio is anchored by heritage branded SKUs, including the Watermelon Frost (西瓜霜) throat/oral-care line, Sanjin Tablets (三金片) for urinary-tract indications, Xuanyunning (眩晕宁) for dizziness/vertigo, Sanqi Blood Injury Powder (三七血伤宁散) for trauma and hemorrhage, Naomaitai Capsules (脑脉泰胶囊) for cerebrovascular indications, and additional compound formulations across tablets, capsules, granules, lozenges, and powders.

The company monetizes primarily through domestic OTC retail, hospital-channel prescription, and wholesale distribution of branded TCM generics in China. Its moat rests on the China Time-honored Brand (中华老字号) recognition (notified 2024-04-30), multi-decade brand equity, and a national distribution footprint across pharmacies and hospitals. Pricing follows standard Chinese branded-generic TCM margins, with revenue mix weighted toward consumer-driven OTC demand supplemented by prescription-channel volume.

Operationally, the company is in a capacity-buildout phase, with a new production warehouse under construction at the Sanjin TCM City manufacturing complex (announced 2025-07-07). FY2024 results showed double-digit year-over-year net profit growth (announced 2025-04-28), and the firm is actively investing in brand equity through leadership recognition (Chairman Zou Xun, National Model Worker, 2025-05-06) and marketing-award activity (National Brand Story Competition, 2025-08-08; 26 C∞l Awards Annual Business Creative Award, 2026-05-21).

Name

Guilin Sanjin Pharmaceutical

Legal name

桂林三金药业股份有限公司

Website

https://sanjin.com.cn

Company type

Public

Founded year

1967

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Guilin Sanjin Pharmaceutical (桂林三金药业) is a publicly listed Chinese traditional Chinese medicine manufacturer (SZSE: 002275, founded 1967) producing branded OTC and prescription TCM products—including Watermelon Frost and Sanjin Tablets—for the domestic Chinese consumer and hospital-channel market.

Ownership category

akta.pro rank

Product category

Traditional Chinese Medicine Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

akta.pro secondary industries

Neurology & CNS Specialty Pharmaceuticals (HLAIACAC), Gastrointestinal & Digestive Health (HLAIADAD)

Keywords

• Traditional Chinese medicine
• Pharmaceutical manufacturing
• Patent medicines
• Herbal preparations
• OTC pharmaceuticals

Headquarters

HQ city

Lingui

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Distribution channels1 record

Core offering

Guilin Sanjin Pharmaceutical manufactures and sells branded Traditional Chinese Medicine (TCM) preparations in multiple dosage forms — tablets, capsules, granules, lozenges, sprays, and powders — addressing therapeutic areas including ENT/throat care (Watermelon Frost series), urology (Sanjin Tablets/Granules), neurology/vertigo (Xuanyunning), cerebrovascular health (Naomaitai), trauma recovery (Sanqi Blood Injury Powder), and gastrointestinal disorders (Compound Tianqi Stomach Pain Capsules). Products are sold under the Sanjin (三金) and Guilin Watermelon Frost (桂林西瓜霜) sub-brands through China's pharmaceutical distribution channels.

Product overview

Guilin Sanjin Pharmaceutical (桂林三金药业股份有限公司) is a traditional Chinese medicine (TCM) pharmaceutical manufacturer offering a portfolio of branded TCM preparations. The product portfolio consists of multiple dosage forms — tablets, capsules, granules, and powder-based formulations — organized under flagship brands including the Sanjin (三金) family (Sanjin Tablets, Sanjin Granules), the Watermelon Frost (西瓜霜) family (Guilin Watermelon Frost, Watermelon Frost Throat Lozenges, Watermelon Frost Throat Lozenges, Guilin Watermelon Frost Capsules), and specialized branded products such as Xuanyunning (眩晕宁) in both tablet and granule forms, Naomaitai Capsules, Sanqi Blood Injury Powder, Compound Red Root Grass Tablets, and Compound Tianqi Stomach Pain Capsules. The company is recognized as a '中华老字号' (Time-Honored Brand), reflecting its heritage in TCM manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• 三金 (Sanjin): Main pharmaceutical brand for products including Sanjin Tablets and Sanjin Granules
• 桂林西瓜霜 (Guilin Watermelon Frost)

Products and services

• Sanjin Tablets (三金片) A core proprietary Traditional Chinese Medicine tablet formulation under the Sanjin (三金) brand, used as a flagship treatment for urinary tract and related urological indications. Targeted at consumers and patients seeking TCM-based urological care.
• Guilin Watermelon Frost (桂林西瓜霜)
• Watermelon Frost Throat Lozenges (西瓜霜润喉片)
• Watermelon Frost Throat Lozenges — Clear Throat variant (西瓜霜清咽含片)
• Guilin Watermelon Frost Capsules (桂林西瓜霜胶囊)
• Naomaitai Capsules (脑脉泰胶囊)
• Xuanyunning Tablets (眩晕宁片)
• Xuanyunning Granules (眩晕宁颗粒)
• Sanqi Blood Injury Powder (三七血伤宁散)
• Compound Red Root Grass Tablets (复方红根草片)
• Compound Tianqi Stomach Pain Capsules (复方田七胃痛胶囊)
• Sanjin Granules (三金颗粒)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Yunnan Baiyao Group Co., Ltd. One of China's largest and most recognized TCM conglomerates with a branded heritage portfolio. Significantly larger than Sanjin but directly comparable in business model: proprietary TCM formulations, strong consumer brand equity, and diversified therapeutic coverage.
• Beijing Tongrentang Co., Ltd. One of China's most prestigious TCM heritage brands, also designated a '中华老字号'. Operates a much larger and more diversified TCM portfolio, including retail pharmacy chains, providing a benchmark for Sanjin's growth trajectory in the heritage TCM space.
• Pien Tze Huang Pharmaceutical Co., Ltd. Premium Chinese TCM brand with a flagship heritage product (Pien Tze Huang). Larger than Sanjin but comparable in business model: branded proprietary TCM, high consumer recognition, and pricing power anchored by heritage status.
• Guangzhou Baiyunshan Pharmaceutical Holdings: Large state-owned Chinese pharmaceutical group with substantial TCM operations, including branded consumer health products. While much larger in scale, it competes in similar OTC TCM channels and therapeutic categories, making it a relevant incumbent comparable.
• Shanghai Pharmaceuticals Holding: One of China's largest pharmaceutical conglomerates with significant TCM and consumer health operations. Provides scale benchmark and competitive context for Sanjin's positioning in branded TCM and pharmaceutical distribution.

Direct peers

• China Resources Sanjiu Medical & Pharmaceutical: Major Chinese TCM pharmaceutical manufacturer with similar product breadth across OTC and prescription TCM categories. Comparable size and business model in the branded Chinese medicine space, with overlapping therapeutic areas including respiratory, GI, and chronic disease management.
• Livzon Pharmaceutical Group: Mid-sized Chinese pharmaceutical company with both chemical drug and TCM operations. Comparable scale to Sanjin with overlapping therapeutic areas (GI, cardiovascular) and similar position as a publicly listed Chinese pharma on the SZSE/SSE.
• Shandong Dong-E E-Jiao Co., Ltd. Branded Chinese TCM manufacturer with a heritage product portfolio (E-Jiao/donkey-hide gelatin) and similar scale to Sanjin. Comparable heritage-driven brand strategy and product mix focused on traditional Chinese medicinal formulations.
• China Traditional Chinese Medicine Holdings: Pure-play Chinese TCM manufacturer with branded formulations across multiple therapeutic areas. Closely comparable in product positioning, scale, and focus on traditional Chinese medicine preparations distributed through China's pharmaceutical network.

Others

• Jointown Pharmaceutical Group: One of China's largest pharmaceutical distributors and supply chain operators. Relevant as a channel partner / customer for Sanjin's products and as a representative of the distribution network through which Sanjin reaches end markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/guilin-sanjin-pharmaceutical-co-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Guilin Sanjin Pharmaceutical